Veraflox
60 mg
EU/2/10/107/005
Bayer Animal Health , Vācija
QJ01MA97
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Pradofloxacin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
07-Jan-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/10/107/005
60 mg
1
Blisteris, 7 tablete
-
REXXOLIDE
100 mg/ml
EU/2/20/263/002
Dechra Regulatory B.V., Nīderlande
QJ01FA94
cattle; pigs; sheep
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Tulathromycin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Eurovet Animal Health B.V., Nīderlande
Date of authorisation/renewal:
03-Dec-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/263/002
100 mg/ml
1
Stikla flakons, 100 ml
-
Vectormune FP ILT
-
EU/2/20/266/006
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
-
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Live recombinant fowlpox virus
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal:
09-Dec-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/266/006
10
Stikla flakons, 2000 devas/flakonā
-
Versican Plus L4
-
EU/2/14/171/001
Zoetis Belgium S.A., Beļģija
QI07AB01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Inactivated Leptospira interrogans serovar Canicola, strain MSLB 1090,Leptospira kirschneri serovar Grippotyphosa, strain MSLB 1091,Leptospira interrogans serovar Bratislava, strain MSLB 1088,Leptospira interrogans serovar Icterohaemorrhagia, strain MSLB 1089
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Bioveta, a.s., Čehija
Date of authorisation/renewal:
10-Apr-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/14/171/001
25
Stikla flakons, 1 deva
-
Porcilis ColiClos
-
EU/2/12/141/005
Intervet International B.V., Nīderlande
QI09AB08
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,LT toxoid,F4ac (K88ac) fimbrial adhesin,F6 (987P) fimbrial adhesin,Toxoid Clostridium perfringens, type C
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
14-Jun-2012
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/12/141/005
250 deva
1
Flakons, 250 deva
-
Veraflox
120 mg
EU/2/10/107/011
Bayer Animal Health , Vācija
QJ01MA97
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Pradofloxacin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
07-Jan-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/10/107/011
120 mg
10
Blisteris, 7 tablete
-
Vectra 3D
-
EU/2/13/156/006
Ceva Sante Animale, Francija
QP53AC54
small dogs
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Permethrin,Pyriproxyfen,Dinotefuran
Distribution category:
Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release
Ceva Sante Animale, Francija
Date of authorisation/renewal:
27-Aug-2018
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/13/156/006
1
Pipete, 1 deva
-
NexGard Combo
-
EU/2/20/267/008
Boehringer Ingelheim Vetmedica GmbH, Vācija
QP54AA54
cats 2.5-7.5 kg
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Esafoxolaner, Eprinomectin, Praziquantel
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Animal Health France SCS., Francija
Date of authorisation/renewal:
06-Jan-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/267/008
6
Aplikators, 0,9 ml
-
Locatim
-
EU/2/99/011/001
Melchior Sante Animale, Francija
QI02AT01
newborn calves
Vairāk
Medicinal product information
Pharmaceutical form:
solution for oral use
International name (active substance):
Immunoglobulins against Escherichia coli K99 antigen, Bovine
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
MERIAL Laboratoire Porte des Alpes, Francija
Date of authorisation/renewal:
28-Apr-2004
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/99/011/001
1
Stikla pudelīte, 60 ml
-
Onsior
40 mg
EU/2/08/089/019
Elanco GmbH, Vācija
QM01AH91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Robenacoxib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
Date of authorisation/renewal:
15-Dec-2013
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/08/089/019
40 mg/tabl.
70
Alumīnija blisteris, 1 tablete
-
Oxmax
65 mg/ml
EU/2/23/299/001
New Alpha Innovation Biopharmaceutical Ireland Limited , Īrija
QB05AA91
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
solution for infusion
International name (active substance):
Hemoglobin betafumaril, bovine
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
19-Oct-2023
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/23/299/001
2
Etilēnvinilacetāts (EVA) maisiņš, 100 ml
-
Loxicom
1.5 mg/ml
EU/2/08/090/032
Norbrook Laboratories (Ireland) Limited, Īrija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
12-Mar-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/08/090/032
1,5 mg/ml
1
Polietilēna pudele, 200 ml
-
Enteroporc Coli AC
-
EU/2/20/262/001
Ceva Sante Animale,, Francija
QI09AB08
gilt; Pregnant sow
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and suspension for suspension for injection
International name (active substance):
Clostridium perfringens alpha toxoid, Clostridium perfringens beta1 toxoid, Clostridium perfringens beta2 toxoid, F4ab fimbrial adhesin of E. coli, F4ac fimbrial adhesin of E. coli, F5 fimbrial adhesin of E. coli, F6 fimbrial adhesin of E. coli
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
IDT Biologika GmbH, Vācija
Date of authorisation/renewal:
09-Dec-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/262/001
1
Flakons (suspensija stikla flakonā), 10 deva
-
Trilocur
50 mg/ml
EU/2/24/312/008
Emdoka bvba, Beļģija
QH02CA01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Trilostane
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
06-May-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/312/008
50 mg/ml
1
Polipropilēna pudele, 100 ml
-
Vectormune FP ILT + AE
ml
EU/2/20/250/004
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
-
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Live recombinant fowlpox virus, Avian encephalomyelitis virus, strain Calnek 1143 (AE)
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal:
24-Apr-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/250/004
5
Stikla flakons, 2000 devas/flakonā
-
Loxitab
2.5 mg
EU/2/23/301/006
CP-Pharma Handelsgesellschaft GmbH, Vācija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
19-Oct-2023
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/23/301/006
3
PVH/PE/PVDH-Al blisteris, 10 tablete
-
Oxyglobin
130 mg/ml
EU/2/99/015/002
Biopure Netherlands B.V., Nīderlande
QB05AA90
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
solution for infusion
International name (active substance):
Haemoglobin glutamer-200 (bovine)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Dales Pharmaceuticals Ltd., Lielbritānija
Date of authorisation/renewal:
01-Oct-2009
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/99/015/002
130 mg/ml
2
Maisiņš, 60 ml
-
Daxocox
15 mg
EU/2/21/270/005
Ecuphar NV, Beļģija
QM01AH95
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Enflicoxib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Lelypharma B.V., Nīderlande
Date of authorisation/renewal:
20-Apr-2021
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/21/270/005
15 mg
6
Blisteris, 4 tablete
-
Nobivac L4
-
EU/2/12/143/002
Intervet International B.V, Nīderlande
QI07AB01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000),L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001),L. interrogans serogroup Australis serovar Bratislava (strain As-05-073),L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
15-Jul-2022
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/12/143/002
1 deva
10
Flakons, 1 deva
-
Tulissin
25 mg/ml
EU/2/20/252/012
VIRBAC, Francija
QJ01FA94
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Tulathromycin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
FAREVA AMBOISE, Francija;VIRBAC, Francija
Date of authorisation/renewal:
24-Apr-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/252/012
25 mg/ml
1
Stikla flakons, 250 ml
-